We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+5.63%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$406M
AUM Growth
-$32.3M
Cap. Flow
-$132M
Cap. Flow %
-32.56%
Top 10 Hldgs %
49.27%
Holding
151
New
39
Increased
19
Reduced
25
Closed
51

Top Buys

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$31.3M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$19.6M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$7.25M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$6.43M
5
AGN
Allergan Inc
AGN
+$6.23M

Top Sells

Rank Stock Value
1
SMMF
Summit Financial Group, Inc.
SMMF
+$116M
2
GSK icon
GSK
GSK
+$19M
3
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$15.2M
4
LLY icon
Eli Lilly
LLY
+$11.9M
5
SNY icon
Sanofi
SNY
+$10.6M

Sector Composition

Rank Sector Weight
1 Healthcare 73.98%
2 Technology 4.07%
3 Consumer Discretionary 3.5%
4 Industrials 2.92%
5 Communication Services 1.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MBOT icon
76
Microbot Medical
MBOT
$116M
$1.01M 0.25%
+309
New +$713K
OCRX
77
DELISTED
Ocera Therapeutics, Inc.
OCRX
$971K 0.24%
127,048
+5,900
+5% +$47K
PLXP
78
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$916K 0.23%
11,800
-3,825
-24% -$297K
SLXP
79
CALL
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$915K 0.23%
+500
New +$55.3K
WINT
80
DELISTED
Windtree Therapeutics Inc
WINT
$890K 0.22%
35,714
– –
KBIO
81
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
$821K 0.2%
45,000
– –
GSK icon
82
CALL
GSK
GSK
$104B
$698K 0.17%
2,400
– –
ORA icon
83
Ormat Technologies
ORA
$6B
$677K 0.17%
23,472
– –
TGTX icon
84
TG Therapeutics
TGTX
$7.96B
$563K 0.14%
60,000
-140,000
-70% -$895K
IPXL
85
CALL
DELISTED
Impax Laboratories, Inc.
IPXL
$550K 0.14%
1,000
– –
CORI
86
DELISTED
Corium International, Inc.
CORI
$537K 0.13%
+69,100
New +$521K
PHIO icon
87
Phio Pharmaceuticals
PHIO
$11.8M
– –
0
– –
SMMF
88
DELISTED
Summit Financial Group, Inc.
SMMF
$455K 0.11%
777
-10,920,879
-100% -$116M
SPY icon
89
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$338K 0.08%
+1,500
New +$285K
CYTK icon
90
Cytokinetics
CYTK
$10.5B
$311K 0.08%
65,100
-64,900
-50% -$396K
INSM icon
91
CALL
Insmed
INSM
$21.4B
$293K 0.07%
1,000
– –
ELLO icon
92
Ellomay Capital Ltd
ELLO
$270M
$192K 0.05%
20,564
-80,289
-80% -$799K
TEVA icon
93
PUT
Teva Pharmaceuticals
TEVA
$40.8B
$80K 0.02%
+1,000
New +$51.1K
TISA
94
DELISTED
TOP Image Systems Ltd
TISA
$79K 0.02%
+20,000
New +$79.2K
TJX icon
95
CALL
TJX Companies
TJX
$174B
$69K 0.02%
+1,000
New +$28.5K
AUXL
96
CALL
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$40K 0.01%
935
– –
VRTX icon
97
PUT
Vertex Pharmaceuticals
VRTX
$121B
$13K ﹤0.01%
+1,500
New +$105K
BFH icon
98
Bread Financial
BFH
$4.37B
– –
-5,759
Closed -$1.25M
BLUE
99
DELISTED
bluebird bio
BLUE
– –
-4,434
Closed -$1.31M
CGEN icon
100
Compugen
CGEN
$222M
– –
-69,109
Closed -$726K
2 3
4
5 6

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q2 2014 Portfolio in Review

As of Q2 2014, Sphera Funds Management held 151 positions worth $406M, down 7.4% from $438M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Sphera Funds Management withdrew a net $132M in Q2 2014, closing 51 positions and reducing 25 holdings. Its most notable exit was State Street Financial Select Sector SPDR ETF, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, up from 74% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Sphera Funds Management opened a new position in Shire pic worth $14.1M.

  • Sphera Funds Management's largest Q2 2014 buy was Shire pic: 180,000 shares worth $14.1M.
  • Sphera Funds Management added most to Teva Pharmaceuticals in Q2 2014, an estimated $19.6M increase.
  • Sphera Funds Management's biggest Q2 2014 reduction was Summit Financial Group, Inc., cutting an estimated $116M.
  • Sphera Funds Management fully exited State Street Financial Select Sector SPDR ETF in Q2 2014, selling an estimated $15.2M.
  • Sphera Funds Management's ten largest holdings make up 49% of its $406M portfolio in Q2 2014.
  • Sphera Funds Management opened 39 new positions and closed 51 in Q2 2014.
  • Sphera Funds Management's portfolio value fell 7.4% quarter-over-quarter to $406M.

Based on Sphera Funds Management's 13F filing for Q2 2014, filed 11 Aug 2014.